Neuraxis, INC [Rocket]

In millions, except per share items	Sep-30-22	Dec-31-21	Sep-30-21	Dec-31-20
	S-1/A	S-1/A	S-1/A	S-1/A
Revenues:
License revenue				0.3
Net Sales		2.7		1.9
Total revenues [+]		2.7		2.2
Licensing				0.3
Products		2.7		1.9
Revenue growth [+]		24.8%
Net Sales		41.0%
Cost of goods sold		0.5		0.5
Gross profit		2.3		1.7
Gross margin		82.8%		77.9%
Selling, general and administrative [+]		5.0		5.4
Sales and marketing		0.5		0.5
General and administrative		4.6		4.9
Research and development		0.2		0.2
Other operating expenses				0.3
EBITDA [+]		-2.9		-4.1
EBITDA growth		-28.2%
EBITDA margin		-107.8%		-187.4%
Depreciation and amortization		0.0		0.0
EBIT [+]		-3.0		-4.1
EBIT growth		-27.9%
EBIT margin		-109.1%		-189.0%
Interest expense, net [+]		0.0		0.1
Interest expense		0.0		0.1
Interest income				0.0
Other income (expense), net [+]		0.0		0.5
Other				0.0
Pre-tax income		-3.0		-3.7
Income taxes		0.0		0.0
Tax rate		0.0%		0.0%
Net income		-3.0		-3.7
Net margin		-111.3%		-170.9%

Basic EPS [+]		($1.54)		($1.89)
Growth		-18.7%
Diluted EPS [+]		($1.54)		($1.89)
Growth		-18.7%

Shares outstanding (basic)		2.0		2.0
Growth		0.0%
Shares outstanding (diluted)		2.0		2.0
Growth		0.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.